Solifenacin Improved Warning Time Significantly Compared to Placebo in Patients with Overactive Bladder

Toglia M1, Andoh M2, Hussain I2 1. Urogynecology Associates of Philadelphia, Media, PA, 2. Astellas Pharma, Inc., Deerfield, IL

Abstract Category

Detrusor Overactivity

Abstract 123
Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14
Friday 1st December 2006
09:00 - 09:07